Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 221 clinical trials
Integrative Management of Patients With Atrial Fibrillation Via Hospital-Community-Family-Based Telemedicine (HCFT-AF) Program

by year. The treatment of atrial fibrillation involves many aspects such as switching to sinus rhythm, controlling heart rate and anticoagulant therapy, which is a long course affecting the adherence

anticoagulant therapy
heart failure
fibrillation
arrhythmia
anticoagulants
  • 5 views
  • 17 Feb, 2022
  • 1 location
COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

patients receive the anticoagulant with the greatest balance of benefit to potential harm. The trial is to assess bleeding rates and superiority of using apixaban versus rivaroxaban in patients

anticoagulants
apixaban
rivaroxaban
electrocardiogram
warfarin
  • 4 views
  • 11 Nov, 2021
  • 1 location
Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)

generation drug eluting stent (DES) implantation at 70 centers nationwide in China and contains two sub-studies. In the OPTIMA-3 sub-study, 2274 subjects who choose warfarin as anticoagulant will

aspirin
acute coronary syndrome
clopidogrel
thrombosis
ticagrelor
  • 51 views
  • 03 May, 2022
  • 1 location
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF) (ENRICH-AF)

To assess whether edoxaban (60/30 mg daily) compared to non-antithrombotic medical therapy (either no antithrombotic therapy or antiplatelet monotherapy) reduces the risk of stroke (composite of ischemic, hemorrhagic and unspecified stroke) in high-risk atrial fibrillation (CHA2DS2-VASc 2) patients with previous intracranial hemorrhage.

vascular disease
edoxaban
atrial fibrillation
fibrillation
anticoagulants
  • 15 views
  • 16 Feb, 2022
  • 140 locations
WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation (CHAMPION-AF)

The primary objective of this study is to determine if left atrial appendage closure (LAAC) with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.

vascular disease
hypertension
anticoagulants
left atrial appendage closure
vitamin k
  • 131 views
  • 25 Oct, 2022
  • 141 locations
New Model of Integrated Care of Older Patients With Atrial Fibrillation in Rural China

This cluster randomization study aims to compare the people-centered integrated care versus usual care to improve outcome of older patients with atrial fibrillation in rural China.

  • 0 views
  • 26 Jan, 2021
  • 1 location
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG (PACES)

The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated coronary artery bypass graft (CABG) surgery. All patients with a qualifying …

thromboembolism
vitamin k antagonist
anticoagulants
ticagrelor
apixaban
  • 112 views
  • 18 Oct, 2022
  • 47 locations
PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) (PROTEST)

This is a pilot study, phase III, multi-centre, double blind, randomized controlled trial of patients with traumatic brain injury (TBI).

traumatic brain injury
severe traumatic brain injury
subarachnoid hemorrhage
  • 119 views
  • 16 Feb, 2022
  • 10 locations
Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Trial of the Efficacy and Safety of SPT-07A Injection in Patients With Acute Ischemic Stroke (SPAIR-2)

This is a multicenter, randomized, double-blind, placebo-controlled, parallel controlled clinical trial in Chinese patients with acute ischemic stroke. Objective to evaluate the efficacy and safety of SPT-07A injection compared with placebo in the treatment of patients with acute ischemic stroke.

  • 0 views
  • 10 Oct, 2022
  • 1 location
Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease

The TRACK trial is an investigator-initiated, multicentre, prospective, randomised, double-blind, placebo-controlled trial. TRACK is a global trial and will be conducted in renal units that provide comprehensive CKD care. Approximately 2000 participants will be recruited. The TRACK trial will assess a strategy of administering low dose rivaroxaban to reduce the …

dialysis
  • 2 views
  • 04 Oct, 2022
  • 34 locations